Krista Hessler Carver

Krista Hessler Carver maintains a broad FDA regulatory practice that includes advocating for policy changes. She counsels a variety of companies on complex matters, including responses to the Inflation Reduction Act.

Krista Hessler Carver counsels pharmaceutical and biotechnology businesses on legislative and regulatory developments and procedure, including Hatch-Waxman compliance, life cycle management, digital health and orphan drugs.